Harvard Bioscience (HBIO) EBIT Growth (1y) (2011 - 2026)
Harvard Bioscience (HBIO) EBIT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 30.74% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -75.72% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -26.09% |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 17.25% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 16.53% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -116.77% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -46.71% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 8.28% |
| 10 | Harvard Bioscience | 28.05 Mn | 20.96 Mn | 12.24 Mn | 97.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 97.64% |
| Dec 31, 2025 | 15,445.45% |
| Sep 30, 2025 | 110.51% |
| Jun 30, 2025 | 60.42% |
| Mar 31, 2025 | -2,079.38% |
| Dec 31, 2024 | -96.10% |
| Sep 30, 2024 | -100.86% |
| Jun 30, 2024 | -359.92% |
| Mar 31, 2024 | -230.30% |
| Dec 31, 2023 | 161.71% |
| Sep 30, 2023 | 75.20% |
| Jun 30, 2023 | -80.09% |
| Mar 31, 2023 | 126.06% |
| Dec 31, 2022 | -126.90% |
| Sep 30, 2022 | -786.50% |
| Jun 30, 2022 | 6,793.10% |
| Mar 31, 2022 | -2,708.37% |
| Dec 31, 2021 | -38.35% |
| Sep 30, 2021 | 201.10% |
| Jun 30, 2021 | -89.57% |